Decitabine With or Without Micro-Transplantation for the Treatment of Intermediate or High-Risk Myelodysplastic Syndrome: A Chinese Single-Center Retrospective Study of 22 Patients

The treatment outcomes of intermediate or high-risk myelodysplastic syndrome (MDS) remain unsatisfactory. This study was designed to evaluate the safety and efficacy of human leukocyte antigen (HLA)-mismatched hematopoietic stem cell micro-transplantation (MST) in patients with MDS. A total of 22 pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, MinMing, Li, Chao, Geng, SuXia, Chen, XiaoMei, Wu, Ping, Deng, ChengXin, Chen, XiaoFang, Lu, ZeSheng, Weng, JianYu, Du, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8044401/
https://www.ncbi.nlm.nih.gov/pubmed/33869012
http://dx.doi.org/10.3389/fonc.2021.628127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8044401/
https://www.ncbi.nlm.nih.gov/pubmed/33869012
http://dx.doi.org/10.3389/fonc.2021.628127

Ejemplares similares